ETC
KYMR icon

Exchange Traded Concepts’s Kymera Therapeutics KYMR Stock Holding History

Exchange Traded Concepts’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,693
Closed -$101K – 1469
2025
Q1 		$101K Buy
3,693
+239
+7% +$8.71K ﹤0.01% 1160
2024
Q4 		$139K Hold
3,454
– – ﹤0.01% 1079
2024
Q3 		$163K Sell
3,454
-2,048
-37% -$90.4K ﹤0.01% 1026
2024
Q2 		$164K Sell
5,502
-1,710
-24% -$59.2K ﹤0.01% 897
2024
Q1 		$290K Sell
7,212
-147
-2% -$5.26K 0.01% 810
2023
Q4 		$187K Buy
7,359
+1,866
+34% +$33.4K 0.01% 795
2023
Q3 		$76.4K Buy
5,493
+53
+1% +$1.07K ﹤0.01% 967
2023
Q2 		$125K Buy
+5,440
New +$156K ﹤0.01% 895

Other funds holding KYMR

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return